KEWAUNEE SCIENTIFIC CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.9 USD | -2.92% |
|
-1.30% | +20.06% |
| 07/03 | Kewaunee Scientific Shares Fall After Company Posts Lower Fiscal Q3 Net Sales | MT |
| 06/03 | Earnings Flash (KEQU) KEWAUNEE SCIENTIFIC CORPORATION Posts Q3 Revenue $46.8M | MT |
| Sales 2022 | 169M 14.08B | Sales 2023 | 219M 18.3B | Capitalization | 45.99M 3.83B |
|---|---|---|---|---|---|
| Net income 2022 | -6M -500M | Net income 2023 | - 0 | EV / Sales 2022 | 0.44 x |
| Net Debt 2022 | 34.36M 2.86B | Net Debt 2023 | 33.62M 2.8B | EV / Sales 2023 | 0.36 x |
| P/E ratio 2022 |
-6.48
x | P/E ratio 2023 |
65
x | Employees | 982 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 74.33% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -2.92% | ||
| 1 week | -1.30% | ||
| Current month | +1.45% | ||
| 1 month | +5.79% | ||
| 3 months | +20.14% | ||
| 6 months | +91.23% | ||
| Current year | +20.06% |
1 week
34.60
36.90
1 month
33.1236.90
Current year
27.0036.90
1 year
14.5636.90
3 years
11.4436.90
5 years
6.9636.90
10 years
6.9638.80
| Managers | Title | Age | Since |
|---|---|---|---|
Thomas Hull
CEO | Chief Executive Officer | 48 | 01/15/01 |
Donald Gardner
DFI | Director of Finance/CFO | 45 | 29/19/29 |
Mandar Ranade
CTO | Chief Tech/Sci/R&D Officer | 50 | 02/19/02 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
David Rhind
CHM | Chairman | 61 | 01/08/01 |
Donald Shaw
BRD | Director/Board Member | 73 | 01/13/01 |
Keith Gehl
BRD | Director/Board Member | 65 | 29/15/29 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 34.9 | -2.92% | 4,401 |
| 25/24/25 | 35.95 | -0.69% | 6,160 |
| 24/24/24 | 36.2 | -0.55% | 3,550 |
| 23/24/23 | 36.4 | +2.77% | 11,409 |
| 22/24/22 | 35.42 | +0.17% | 13,699 |
Delayed Quote Nasdaq, April 27, 2024 at 02:00 am IST
More quotes
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture products. The Company operates through two segments: Domestic and International. The Domestic business segment principally designs, manufactures, and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, casework, flexible systems, worksurfaces, workstations, workbenches, and computer enclosures. The International business segment consists of foreign subsidiaries, such as Kewaunee Labway Asia Pte. Ltd., Kewaunee Scientific Corporation Singapore Pte. Ltd., Kewaunee Labway India Pvt. Ltd., Koncepo Scientech International Pvt. Ltd., and Kequip Global Lab Solutions Pvt. Ltd. The Company's products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Sector
Business Support Supplies
Calendar
26/06/2024
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +20.06% | 100M | |
| +11.82% | 7.42B | |
| +1.41% | 2.88B | |
| +1.60% | 2.01B | |
| +7.89% | 1.41B | |
| -10.72% | 1.38B | |
| -20.56% | 462M | |
| +0.44% | 432M | |
| -12.72% | 385M | |
| -0.79% | 173M |
- Stock Market
- Equities
- KEQU Stock
